The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 15, 2023
Filed:
Oct. 15, 2015
Applicant:
Xenothera, Nantes, FR;
Inventors:
Odile Duvaux, Nantes, FR;
Jean-Paul Soulillou, Nantes, FR;
Assignee:
Xenothera, Nantes, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/08 (2006.01); A01K 67/027 (2006.01); C07K 16/06 (2006.01); C12P 21/00 (2006.01); C07K 16/12 (2006.01); C07K 16/10 (2006.01); A61K 39/00 (2006.01); C12N 9/10 (2006.01); C07K 16/44 (2006.01); C12N 9/02 (2006.01);
U.S. Cl.
CPC ...
C07K 16/08 (2013.01); A01K 67/0276 (2013.01); C07K 16/06 (2013.01); C07K 16/10 (2013.01); C07K 16/12 (2013.01); C12P 21/005 (2013.01); C12Y 114/18002 (2013.01); C12Y 204/01087 (2013.01); A01K 2217/075 (2013.01); A01K 2217/15 (2013.01); A01K 2227/108 (2013.01); A01K 2267/01 (2013.01); A01K 2267/02 (2013.01); A61K 2039/505 (2013.01); C07K 16/44 (2013.01); C07K 2317/10 (2013.01); C07K 2317/20 (2013.01); C07K 2317/41 (2013.01); C07K 2317/734 (2013.01); C12N 9/0071 (2013.01); C12N 9/1048 (2013.01); C12N 2760/14111 (2013.01);
Abstract
The present invention relates to polyclonal antibodies directed against at least one non-human biological pathogen, or against at least one molecule derived from said pathogen, towards a human or a non-human animal organism, wherein the said polyclonal antibodies are devoid of an antigenic determinant selected in a group comprising (i) N-glycolneuraminic acid (Neu5Gc) and/or (ii) a-1,3-galactose, and their use as a medicament.